Rheumatology and Immunology

Megan Elizabeth Bowles Clowse, MD

Associate Professor of Medicine
Campus mail Baker House 07, Duke South, Trent Drive, Durham, NC 27710
Phone (919) 681-2045
Email address megan.clowse@duke.edu

Dr. Megan Clowse is an Associate Professor of Medicine, Rheumatology and Immunology.  Her clinical research focuses on the management of rheumatologic diseases in pregnancy. Her current studies include identification of causes for the high rate of infertility among women with rheumatoid arthritis and understanding how psoriatic arthritis impacts pregnancy.

She has conducted studies on vasculitis and ovarian function and pregnancy. She is the Director of the Vasculitis-Pregnancy Registry, an online pregnancy registry for women with these rare conditions.  Additionally, she has collected prospective pregnancies in women with rheumatic disease in the Duke Autoimmunity in Pregnancy Registry that includes clinical data, pregnancy outcomes, and a large sample repository.

In Their Words

Education and Training

  • Fellow in Rheumatology, Medicine, Johns Hopkins University, 2002 - 2005
  • Medical Residetn, Medicine, Johns Hopkins University, 1999 - 2002
  • M.D., Vanderbilt University, 1999
  • M.P.H., University of California at Los Angeles, 1994

Grants

Publications

Clowse, MEB, and McDaniel, G. "AB0284 Reproductive Health in Adult Women with JIA and RA:." June 2016.

Full Text

Wallace, DJ, Hobbs, K, Clowse, MEB, Petri, M, Strand, V, Pike, M, Merrill, JT, Leszczyński, P, Neuwelt, CM, Jeka, S, Houssiau, F, Keiserman, M, Ordi-Ros, J, Bongardt, S, Kilgallen, B, Galateanu, C, Kalunian, K, Furie, R, and Gordon, C. "Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to- Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study." Arthritis care & research 68, no. 4 (April 2016): 534-543.

PMID
26316325
Full Text

Clowse, MEB, Wolf, DC, Förger, F, Cush, JJ, Golembesky, A, Shaughnessy, L, De Cuyper, D, and Mahadevan, U. "Pregnancy Outcomes in Subjects Exposed to Certolizumab Pegol." The Journal of Rheumatology 42, no. 12 (December 2015): 2270-2278.

PMID
26523031
Full Text

Yazdany, J, Myslinski, R, Francisco, M, Bansback, N, Clowse, MEB, Collier, D, Law, K, Liao, K, Michaud, K, Morgan-DeWitt, E, Oates, J, Orozco, C, Reimold, A, Simard, JF, and Kazi, S. "A National Electronic Health Record-Enabled Registry in Rheumatology: The ACR's Rheumatology Informatics System for Effectiveness (RISE).": WILEY-BLACKWELL, October 1, 2015.

Scholars@Duke

Sadun, R, Holdgate, N, Wells, M, Clowse, MEB, Criscione-Schrieber, L, Balevic, S, Lackey, V, Mohammad, S, and Peart, E. "Contraception Use Amongst Women Ages 18-45 Taking Known Teratogenic Medications in an Academic Rheumatology Clinic.": WILEY-BLACKWELL, October 1, 2015.

Scholars@Duke

Sadun, R, Holdgate, N, Wells, M, Clowse, MEB, Criscione-Schrieber, L, Balevic, S, Lackey, V, Mohammad, S, and Peart, E. "Contraception Use Amongst Women Ages 18-45 Taking Known Teratogenic Medications in an Academic Rheumatology Clinic.": WILEY-BLACKWELL, October 1, 2015.

Scholars@Duke

Zhang, J, Curtis, JR, Xie, F, Mannion, ML, Lewis, JD, Clowse, MEB, Saag, KG, Bethard, S, Biggio, J, McGwin, G, and Beukelman, T. "Utilization of Immune-Suppressive Medications during Pregnancy Among Women with Inflammatory Arthritis and Other Autoimmune Diseases.": WILEY-BLACKWELL, October 1, 2015.

Scholars@Duke

Zhang, J, Curtis, JR, Xie, F, Mannion, ML, Lewis, JD, Clowse, MEB, Saag, KG, Bethard, S, Biggio, J, McGwin, G, and Beukelman, T. "Utilization of Immune-Suppressive Medications during Pregnancy Among Women with Inflammatory Arthritis and Other Autoimmune Diseases.": WILEY-BLACKWELL, October 1, 2015.

Scholars@Duke

Clowse, MEB, Wallace, DJ, Furie, R, Petri, M, Pike, M, Leszczynski, P, Neuwelt, CM, Hobbs, K, Keiserman, M, Duca, L, Kalunian, K, Bongardt, S, Stach, C, Beaudot, C, Kilgallen, B, Galateanu, C, and Gordon, C. "Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials.": WILEY-BLACKWELL, October 1, 2015.

Scholars@Duke

Clowse, MEB, Wallace, DJ, Furie, R, Petri, M, Pike, M, Leszczynski, P, Neuwelt, CM, Hobbs, K, Keiserman, M, Duca, L, Kalunian, K, Bongardt, S, Stach, C, Beaudot, C, Kilgallen, B, Galateanu, C, and Gordon, C. "Efficacy and Safety of Epratuzumab in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from Two Phase 3 Randomized, Placebo-Controlled Trials.": WILEY-BLACKWELL, October 1, 2015.

Scholars@Duke

Pages